2017
DOI: 10.1016/j.jalz.2017.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Dementia registries around the globe and their applications: A systematic review

Abstract: Patient registries are valuable tools helping to address significant challenges in research, care, and policy. Registries, well embedded in many fields of medicine and public health, are relatively new in dementia. This systematic review presents the current situation in regards to dementia registries worldwide. We identified 31 dementia registries operating on an international, national, or local level between 1986 and 2016. More than half of the registries aimed to conduct or facilitate research, including p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
86
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 77 publications
(87 citation statements)
references
References 78 publications
1
86
0
Order By: Relevance
“…A patient registry should be designed based on a purpose [36]. Krysinska et al stated that, the two factors of registry objective and investment are influenced by the design and scope of the registry [40]. The first step in designing a registry is to set realistic goals.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A patient registry should be designed based on a purpose [36]. Krysinska et al stated that, the two factors of registry objective and investment are influenced by the design and scope of the registry [40]. The first step in designing a registry is to set realistic goals.…”
Section: Discussionmentioning
confidence: 99%
“…The diversity of goals and features of registries complicates their comparison. Standard data and information coordination allow data comparison across countries and regions [40]. The data elements of registries should be determined to facilitate scientific disciplines to achieve their objectives [36].…”
Section: Discussionmentioning
confidence: 99%
“…Dementia was identified as a priority area for development of a CQR in 2016 by the Australian Commission for Safety and Quality in Heath Care (ACSQHC), based on the high burden of disease, significant consequences of poor-quality care and support from relevant clinical and consumer organisations [21]. Several dementia CQRs have been established internationally, such as the Swedish Dementia Registry (SveDem), Norwegian Dementia Registry (NorKog), and the Danish Dementia Registry [22]. There is evidence that these dementia CQRs "facilitate better diagnosis, management, and care of people with dementia, as well as caregiver support, across the course of the illness" and have great potential to "reduce cost of dementia and improve standards of diagnosis and care" [22].…”
Section: Need For a Clinical Quality Registry For Dementia In Australiamentioning
confidence: 99%
“…Several dementia CQRs have been established internationally, such as the Swedish Dementia Registry (SveDem), Norwegian Dementia Registry (NorKog), and the Danish Dementia Registry [22]. There is evidence that these dementia CQRs "facilitate better diagnosis, management, and care of people with dementia, as well as caregiver support, across the course of the illness" and have great potential to "reduce cost of dementia and improve standards of diagnosis and care" [22].…”
Section: Need For a Clinical Quality Registry For Dementia In Australiamentioning
confidence: 99%
“…Although the development of radical therapeutic strategies remains critical, the importance of creating a registry system for individuals with normal cognitive function at a risk of AD cannot be understated. To ensure that clinical trials targeting mild cognitive impairment (MCI) and the preclinical/early stages of AD are conducted efficiently, it is necessary to establish more appropriate methods for large-scale clinical trial recruitment [ 4 ]. In clinical research aimed at preventing dementia, a large-scale registration system is necessary to make it scale to validate its efficacy.…”
Section: Introductionmentioning
confidence: 99%